Risultati di ricerca
17 ore fa · The DETOUR2 Trial is a prospective, single-arm, international, multi-center clinical evaluation of the novel DETOUR™ System for fully percutaneous femoropopliteal bypass procedures. IRVINE ...
17 ore fa · Endologix’s CEO Matt Thompson said: "The publication of the one-year results confirms the DETOUR System's clinical promise in treating long femoropopliteal lesions.”. The peripheral guidewire ...
17 ore fa · DETOUR™ System Infographics. (Photo: Business Wire) "The publication of the one-year results confirms the DETOUR System's clinical promise in treating long femoropopliteal lesions," said Matt ...
5 ore fa · Consistent with our evidence-based approach, further data on the performance of the DETOUR system in real-world use will be defined in the PTAB-1 post market study." The DETOUR2 Study enrolled 202 patients at 32 sites, and 200 patients were treated with the DETOUR system.
3 ore fa · Endologix announces one-year results of DETOUR2 Trial, demonstrating efficacy of DETOUR System in treating complex superficial femoral artery disease. The system shows low complication rates, excellent primary patency, and minimally invasive approach.
17 ore fa · 00:01:01. FERGUS – A busy Fergus street will soon close for nearly the entire remainder of the year for a full reconstruction project. St. David Street North from St. Andrew Street West to Garafraxa Street will be closed to traffic starting on Monday with construction expected to last until mid-December.
17 ore fa · One-Year Results of the DETOUR2 Trial published in the Journal of Vascular Surgery (JVS)
